Kicking Joe McCarthy Out of the Lab

In April 1954, I was one of thousands of biomedical scientists who gathered as usual for the annual meeting of the Federation of American Societies for Experimental Biology (FASEB). On this occasion, however, we received an unexpected shock. Rumors were circulating—with circumstantial detail that left little doubt as to their truth—that some highly regarded investigators, previously supported in their unclassified research by the U.S. Public Health Service, had found their grant appl

Written byJohn Edsall
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

At this moment, as it happened, newspapers reported that Robert Oppenheimer was under investigation by the Atomic Energy Commission as an alleged security risk. That, of course, was a different kind of problem, but it came as another powerful blow. For many of us, these events brought to a head the unsubstantiated rumors of subversion, supposedly by Communists planted in our midst, that had been fanned into flame by Sen. Joe McCarthy. Although he never did uncover a genuine Communist in the government, he succeeded by his accusations in getting a number of (generally quite innocent) people forced out of their jobs. In April 1954 we could not know that McCarthy's career of denunciations was to fade away in a few months. Fear, especially among bureaucrats in the lower echelons of government, was pervasive. Security agents were under pressure to show their anticommunist zeal by noting any evidence suggesting possible ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies